pirtobrutinib 50 MG Oral Tablet
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
pirtobrutinib 50 MG Oral Tablet
50 MG · Oral Tablet · oral
A form of pirtobrutinib →
pirtobrutinib 50 MG Oral Tablet — Bruton's tyrosine kinase (BTK) inhibitors. Strength, form, class, interactions & more.
Active ingredient
Classification
Bruton's tyrosine kinase (BTK) inhibitorsKinase Inhibitor
Drug interactions
Pirtobrutinib has several interactions with CYP3A inhibitors and inducers, as well as with sensitive substrates of CYP2C8, CYP2C19, CYP3A, P-gp, and BCRP.
- majorstrong CYP3A inhibitors — increased risk of adverse reactions
- majorstrong or moderate CYP3A inducers — reduced efficacy of pirtobrutinib
- moderatesensitive CYP2C8, CYP2C19, CYP3A, P-gp, or BCRP substrates — increased risk of adverse reactions related to these substrates
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication